Skip to main content
OpenTrials

Clinical trial condition

Chemotherapy-induced Nausea and Vomiting

Explore clinical trials studying Chemotherapy-induced Nausea and Vomiting. Study availability and eligibility vary by location and protocol.

84 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Chemotherapy-induced Nausea and Vomiting trial results

Completed

An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects

NCT02434861

Conditions
Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations
  • Parexel Early Phase Unit Baltimore, Maryland, United States
View Trial Details
Completed

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

NCT00104403

Conditions
Chemotherapy-induced Nausea and Vomiting, Nausea, Nausea and Vomiting, Chemotherapy-Induced, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Corona, California, United States
  • GSK Investigational Site Greenbrae, California, United States
  • GSK Investigational Site Loma Linda, California, United States
View all 113 locations
View Trial Details

Related conditions